CDEK
← All organizations

Vanda Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Vanda Pharmaceuticals | Vanda Pharmaceuticals Inc | VANDA PHARMACEUTICALS INC | VANDA PHARMS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jul 1, 2004

First marketed drug

May 6, 2009

First NDA

May 6, 2009

Last known activity

Feb 20, 2026

Timeline

2000s

  1. Jul 1, 2002

    Vanda Pharmaceuticals— Founded

2010s

  1. Jan 31, 2014

    tasimelteon— NDA Organization

  2. Jan 31, 2014

    tasimelteon— NDA Secondary Org

2020s

  1. Mar 18, 2021

    ponesimod— Marketing Organization

Drugs by trial phase (16 distinct, 68 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (4)

Recent trials (50)

Details

Founded
Washington, US Jul 1, 2002
First NDA
May 6, 2009
Last known activity
Feb 20, 2026

Designations held

  • Orphan drug
  • Priority review